Abstract
Non-invasive Screening of Esophageal Varices in Patients with Liver Cirrhosis
Highlights
Given the invasiveness of the Esophago-Gastro-Duodenoscopy (EGD), non-tolerability, and cost, non-invasive evaluation of the patients with compensated cirrhosis is warranted
It was showed that ALBL-PLT score of more than three has a good predictive value in predicting highrisk varices (HRVs) among compensated cirrhotic patients
The results of this study showed that patients with EVs have a significantly higher PAPAS score than those without EVs
Summary
Given the invasiveness of the Esophago-Gastro-Duodenoscopy (EGD), non-tolerability, and cost, non-invasive evaluation of the patients with compensated cirrhosis is warranted. The last Baveno VI consensus has reported that compensated cirrhotic patients who have platelets count > 150.000/mm3 and liver stiffness measurement (LSM < 20 KPs) are less likely to have highrisk varices (HRVs) and can safely avoid screening EGD [1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Afro-Egyptian Journal of Infectious and Endemic Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
